Postpartum depression, also known as PPD, affects a huge amount of women in the United States, according to the American Journal of Obstetrics and Gynecology. The prevalence of postpartum depression was just 9.4% in 2010 and increased to 19.3% in 2021. Zuranolone is a new drug that just became commercially available a few months ago and it's the first pill designed to specifically treat PPD.

Kortney Conley is a new mom who struggled with PPD.

"So it started, I want to say it was after my eight week checkup, because I went to mainly check up and I was fine. And then it took probably about ten weeks because it was shortly after the checkup that I realized I'm struggling and need to get help," says Conley, who created Moms with Moms.

She tried to find counseling but got stuck on a waitlist for weeks. Eventually deciding she needed to talk with someone who understood what she was going through, she started her podcast "Moms with Moms."

"I bring other moms on to talk about things that are taboo and pregnancy, postpartum and depression, because I feel like it's not talked about. And that helps me to know I'm not alone and I'm potentially helping other moms out there who may be struggling. So when I created it, it was an idea to create a network and a community. It’s moms offering moms support with moms on microphones. But what's also great is I've actually had people reach out to me and say, my gosh, I thought I was the only one who dealt with this," Conley said.

Conley's efforts are showing moms everywhere that no one has to go through postpartum depression alone.